Archive - March 2021
Novartis’ canakinumab misses the mark in previously treated NSCLC
Roche withdraws US indication for Tecentriq in bladder cancer
MHRA green light for DemeRx’s opioid use disorder trial
Novartis’ canakinumab fails to improve overall survival in lung cancer trial
CQC publishes new agreement with Equality and Human Rights Commission
Pandemic-Caused PTSD: Treating the Next Health Crisis
Feminine Hygiene: Keep Your Routine Simple
Yescarta gains first FDA approval for indolent follicular lymphoma